About ViveSpoon
Clinical insight, carried forward by a company.
ViveSpoon Inc. was established to address challenges observed in eating-disorder care through research, software, and responsible business development.
Our work originated in clinical practice and research at Kanazawa University. ViveSpoon Inc. now leads the business and works with healthcare institutions, universities, researchers, engineers, and business partners to develop systems that support care.
Verifiable information
Different facts require different evidence.
Company, people, registered-study, and software-development facts are presented with their separate sources and claim boundaries.
Product development
See what internal technical evidence establishes about one research-operations console version deployed in July 2026—and what it does not establish.
Clinical development
Review the public stage, study plan, registered outcomes, and claim boundaries of the Spoon DTx feasibility study listed in jRCT.
Team and research roles
Company positions are separated from university and research responsibilities, with direct links to Kanazawa University, jRCT, and Japan's National Tax Agency.
Company registration
The legal name, registered office, and Japanese Corporate Number can be checked through the National Tax Agency.
What we do
Connecting clinical practice, research, and implementation.
Our work extends beyond building an app. We study the wider system required for software to be used responsibly within healthcare.
Clinical workflow design
We examine where support is needed, then separate what software may assist with from what must remain a clinical decision.
Evidence generation
We work with healthcare and research partners on study design, evaluation, data governance, feasibility, and safe operation.
Implementation readiness
We prepare the quality, regulatory, security, and delivery foundations needed to translate research into clinical settings.
Research origin
Originating from research at Kanazawa University.
We study how changes outside the consulting room may be supported without displacing the relationship between clinician and patient.
Our approach keeps clinical care at the centre. The software is not intended to provide continuous clinician monitoring or emergency response, and its use is governed by the procedures of the relevant healthcare and research setting.
Product development
Implementation and public disclosure are separate questions.
A clinician- and research-operations console has been implemented. One version deployed to a production environment in July 2026 underwent authenticated technical smoke testing.
This is limited internal engineering evidence. It does not establish completion of user acceptance testing, participant enrolment, clinical use, study results, medical-device approval, or public availability. We also do not claim that every current safety-related revision has completed production verification.
Patient-facing and clinician-facing screens, treatment content, navigation, study procedures, and implementation logic are not publicly disclosed because they include confidential product-development information. Any broader disclosure will follow intellectual-property, jurisdiction-specific regulatory, research-ethics, and research-lead review.
Leadership
Founder and Representative Director
Masafumi Kameya founded ViveSpoon after years of clinical practice and research in eating disorders at Kanazawa University Hospital.
He leads clinical problem definition, therapeutic design, research planning, and business development with collaborators across healthcare, research, product, and business.
Company
Company information
- Legal name
- ViveSpoon株式会社
- English name
- ViveSpoon Inc.
- Established
- 2026
- Japanese Corporate Number
- 4220001027520
- Registered office
- Kanazawa University MIRAICHI Research Center, Nu 7 Kakuma-machi, Kanazawa, Ishikawa, Japan
- Representative Director
- Masafumi Kameya
- Activities
- Research and development of software supporting eating-disorder care
- Company website
- vivespoon.com
Contact
Contact ViveSpoon
We welcome enquiries concerning research collaboration, healthcare partnerships, business development, investment, and media.
We do not provide individual medical advice or emergency assistance. Anyone seeking treatment or urgent support should contact a healthcare provider or local emergency service.